Income From Continuing Operations - Nichi-Iko Pharmaceutical Co Ltd (TSE:4541) - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 0.0001 JPY

Updated:

Nichi-Iko Pharmaceutical Co Ltd
Income from Continuing Operations

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

TTM

|

Adjust for Inflation

Nichi-Iko Pharmaceutical Co Ltd
Income from Continuing Operations Peer Comparison

4502

4568

4578

4519

4503

Company		Income from Continuing Operations	CAGR 3Y	CAGR 5Y	CAGR 10Y
N	Nichi-Iko Pharmaceutical Co Ltd TSE:4541	Income from Continuing Operations -¥105.7B	CAGR 3-Years N/A	CAGR 5-Years N/A	CAGR 10-Years N/A
	Takeda Pharmaceutical Co Ltd TSE:4502	Income from Continuing Operations ¥144.2B	CAGR 3-Years -27%	CAGR 5-Years 1%	CAGR 10-Years 3%
	Daiichi Sankyo Co Ltd TSE:4568	Income from Continuing Operations ¥201B	CAGR 3-Years 39%	CAGR 5-Years 16%	CAGR 10-Years 12%
	Otsuka Holdings Co Ltd TSE:4578	Income from Continuing Operations ¥141.7B	CAGR 3-Years -4%	CAGR 5-Years 11%	CAGR 10-Years -1%
	Chugai Pharmaceutical Co Ltd TSE:4519	Income from Continuing Operations ¥326.4B	CAGR 3-Years 16%	CAGR 5-Years 27%	CAGR 10-Years 18%
	Astellas Pharma Inc TSE:4503	Income from Continuing Operations ¥17B	CAGR 3-Years -48%	CAGR 5-Years -40%	CAGR 10-Years -15%

See Also

Based on the financial report for Mar 31, 2022, Nichi-Iko Pharmaceutical Co Ltd's Income from Continuing Operations amounts to -105.7B JPY.

Over the last year, the Income from Continuing Operations growth was -2 372%.

Join more than 139,100+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.